v3.26.3
Schedule of Cash, Cash Equivalents and Marketable Investment Securities (Details) - USD ($)
9 Months Ended 12 Months Ended
Sep. 30, 2026
Dec. 31, 2025
Cash and Cash Equivalents [Line Items]    
Adjusted Cost $ 714,803 $ 11,884,607
Total Unrealized Gains / (Losses)
Fair Value 714,803 11,884,607
Cash and Cash Equivalents 714,803 11,884,607
Marketable Securities
Cash [Member]    
Cash and Cash Equivalents [Line Items]    
Adjusted Cost 714,803 11,884,607
Total Unrealized Gains / (Losses)
Fair Value 714,803 11,884,607
Cash and Cash Equivalents 714,803 11,884,607
Marketable Securities